Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Ownership of Glaukos Corp (GKOS) Triples in 3 Quarters: Are You Missing Out?

Page 1 of 2

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the future holds and how market participants will react to the bountiful news that floods in each day. The S&P 500 Index gained 7.6% in the 12 month-period that ended November 21, while less than 49% of its stocks beat the benchmark. In contrast, the 30 most popular mid-cap stocks among the top hedge fund investors tracked by the Insider Monkey team returned 18% over the same period, which provides evidence that these money managers do have great stock picking abilities. That’s why we believe it isn’t a waste of time to check out hedge fund sentiment before you invest in a stock like Glaukos Corp (NYSE:GKOS).

Glaukos Corp (NYSE:GKOS) investors should be aware of an increase in support from the world’s most elite money managers of late. GKOS was in 19 hedge funds’ portfolios at the end of the third quarter of 2016. There were 16 hedge funds in our database with GKOS holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Orion Engineered Carbons SA (NYSE:OEC), Employers Holdings, Inc. (NYSE:EIG), and BancFirst Corporation (NASDAQ:BANF) to gather more data points.

Follow Glaukos Corp
Trade (GKOS) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

doctor, patient, talking, man, male, physician, senior, older, consultant, medical, smiling, people, helpful, adult, desk, working, usa, american, practitioner, horizontal, taking

Monkey Business Images/Shutterstock.com

What have hedge funds been doing with Glaukos Corp (NYSE:GKOS)?

At Q3’s end, a total of 19 of the hedge funds tracked by Insider Monkey were long this stock, a 19% jump from the previous quarter. Hedge fund ownership has more than tripled in just three quarters as hedgies grow bullish on GKOS’ iStent. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).

HedgeFundSentimentChart

Of the funds tracked by Insider Monkey, OrbiMed Advisors, managed by Samuel Isaly, holds the most valuable position in Glaukos Corp (NYSE:GKOS). OrbiMed Advisors has an $82.3 million position in the stock. On OrbiMed Advisors’ heels is Renaissance Technologies, led by Jim Simons, holding a $26.6 million position. Some other hedge funds and institutional investors that hold long positions contain James E. Flynn’s Deerfield Management, Ken Griffin’s Citadel Investment Group and John Overdeck and David Siegel’s Two Sigma Advisors.

Page 1 of 2
Loading Comments...